Opportunity ID: 252533
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CK-11-0010401SUPP14 |
Funding Opportunity Title: | Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events Multicenter Expansion of Current Investigation |
Opportunity Category: | Continuation |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 4 |
Posted Date: | Mar 14, 2014 |
Last Updated Date: | Mar 19, 2014 |
Original Closing Date for Applications: | Apr 30, 2014 |
Current Closing Date for Applications: | Apr 30, 2014 |
Archive Date: | May 30, 2014 |
Estimated Total Program Funding: | $5,000,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $400,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | 1.Eligible Applicants
Eligible Organizations 2. Foreign Organizations Foreign components of U.S. Organizations are not eligible to apply. For this announcement, applicants may not include collaborators or consultants from foreign institutions. All applicable federal laws and policies apply. 3.Special Eligibility Requirements |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The CDC Prevention Epicenters Program has been established to develop, implement and evaluate the effectiveness of epidemiologically-based strategies to improve healthcare quality and patient safety. This funding opportunity announcement is designed to utilize the CDC Prevention Epicenters Program to translate basic, epidemiologic and technologic discoveries into new strategies for improving prevention of Healthcare-Associated Infections (HAIs), Antimicrobial Resistance (AR) and other adverse events in all types of healthcare facilities in the United States. The prevention strategies could include, but are not limited to, prevention strategies currently undergoing single-center studies by the prevention epicenters program that merit further investigation in multicenter studies. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
A | Mar 19, 2014 | |
App Package | Mar 19, 2014 | |
New closing due date:April 24, 2014 by 5:00 PM U.S. Eastern Time ON Grants.gov. | Mar 19, 2014 | |
Mar 19, 2014 |
DISPLAYING: Synopsis 4
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CK-11-0010401SUPP14 |
Funding Opportunity Title: | Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events Multicenter Expansion of Current Investigation |
Opportunity Category: | Continuation |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 4 |
Posted Date: | Mar 14, 2014 |
Last Updated Date: | Mar 19, 2014 |
Original Closing Date for Applications: | Apr 30, 2014 |
Current Closing Date for Applications: | Apr 30, 2014 |
Archive Date: | May 30, 2014 |
Estimated Total Program Funding: | $5,000,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $400,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | 1.Eligible Applicants
Eligible Organizations 2. Foreign Organizations Foreign components of U.S. Organizations are not eligible to apply. For this announcement, applicants may not include collaborators or consultants from foreign institutions. All applicable federal laws and policies apply. 3.Special Eligibility Requirements |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The CDC Prevention Epicenters Program has been established to develop, implement and evaluate the effectiveness of epidemiologically-based strategies to improve healthcare quality and patient safety. This funding opportunity announcement is designed to utilize the CDC Prevention Epicenters Program to translate basic, epidemiologic and technologic discoveries into new strategies for improving prevention of Healthcare-Associated Infections (HAIs), Antimicrobial Resistance (AR) and other adverse events in all types of healthcare facilities in the United States. The prevention strategies could include, but are not limited to, prevention strategies currently undergoing single-center studies by the prevention epicenters program that merit further investigation in multicenter studies. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CK-11-0010401SUPP14 |
Funding Opportunity Title: | Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events ¿ Multicenter Expansion of Current Investigation |
Opportunity Category: | Continuation |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Mar 19, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Apr 30, 2014 |
Archive Date: | May 30, 2014 |
Estimated Total Program Funding: | $5,000,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $400,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | 1.Eligible Applicants
Eligible Organizations 2. Foreign Organizations Foreign components of U.S. Organizations are not eligible to apply. For this announcement, applicants may not include collaborators or consultants from foreign institutions. All applicable federal laws and policies apply. 3.Special Eligibility Requirements |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The CDC Prevention Epicenters Program has been established to develop, implement and evaluate the effectiveness of epidemiologically-based strategies to improve healthcare quality and patient safety. This funding opportunity announcement is designed to utilize the CDC Prevention Epicenters Program to translate basic, epidemiologic and technologic discoveries into new strategies for improving prevention of Healthcare-Associated Infections (HAIs), Antimicrobial Resistance (AR) and other adverse events in all types of healthcare facilities in the United States. The prevention strategies could include, but are not limited to, prevention strategies currently undergoing single-center studies by the prevention epicenters program that merit further investigation in multicenter studies. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CK-11-0010401SUPP14 |
Funding Opportunity Title: | Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events ¿ Multicenter Expansion of Current Investigation |
Opportunity Category: | Continuation |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 19, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Apr 24, 2014 |
Archive Date: | May 30, 2014 |
Estimated Total Program Funding: | $5,000,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $400,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | 1.Eligible Applicants
Eligible Organizations 2. Foreign Organizations Foreign components of U.S. Organizations are not eligible to apply. For this announcement, applicants may not include collaborators or consultants from foreign institutions. All applicable federal laws and policies apply. 3.Special Eligibility Requirements |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The CDC Prevention Epicenters Program has been established to develop, implement and evaluate the effectiveness of epidemiologically-based strategies to improve healthcare quality and patient safety. This funding opportunity announcement is designed to utilize the CDC Prevention Epicenters Program to translate basic, epidemiologic and technologic discoveries into new strategies for improving prevention of Healthcare-Associated Infections (HAIs), Antimicrobial Resistance (AR) and other adverse events in all types of healthcare facilities in the United States. The prevention strategies could include, but are not limited to, prevention strategies currently undergoing single-center studies by the prevention epicenters program that merit further investigation in multicenter studies. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CK-11-0010401SUPP14 |
Funding Opportunity Title: | Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events ¿ Multicenter Expansion of Current Investigation |
Opportunity Category: | Continuation |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 5 |
Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 19, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Apr 30, 2014 |
Archive Date: | May 30, 2014 |
Estimated Total Program Funding: | $5,000,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $400,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | 1.Eligible Applicants
Eligible Organizations 2. Foreign Organizations Foreign components of U.S. Organizations are not eligible to apply. For this announcement, applicants may not include collaborators or consultants from foreign institutions. All applicable federal laws and policies apply. 3.Special Eligibility Requirements |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The CDC Prevention Epicenters Program has been established to develop, implement and evaluate the effectiveness of epidemiologically-based strategies to improve healthcare quality and patient safety. This funding opportunity announcement is designed to utilize the CDC Prevention Epicenters Program to translate basic, epidemiologic and technologic discoveries into new strategies for improving prevention of Healthcare-Associated Infections (HAIs), Antimicrobial Resistance (AR) and other adverse events in all types of healthcare facilities in the United States. The prevention strategies could include, but are not limited to, prevention strategies currently undergoing single-center studies by the prevention epicenters program that merit further investigation in multicenter studies. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
Related Documents
Packages
Agency Contact Information: | Centers for Disease Control and Prevention (CDC) Procurement and Grants Office (PGO) Phone: 770-488-2700 Email: pgotim@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.084 | NCEZID-R-S | Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events Multicenter Expansion of Current Investigation | PKG00193978 | Mar 14, 2014 | Apr 30, 2014 | View |